Trialbee recognized as one of the most innovative health tech startups in the world serving the life science industry
As one of ten European startups selected by the Accenture HealthTech Innovation Challenge jury, Trialbee will attend the regional round in London on November 3rd.
The selected companies will pitch their solutions, and ultimately compete for a place in the grand final at the StartUp Health Festival in San Francisco, January 2018.
“We are proud to be recognized and selected by Accenture for our innovation in bringing medicinal products to patients in a more effective way,” says Tobias Folkesson, CEO for Trialbee and continues:
“Digitalization of the clinical trial process simplifies product development, makes delivery milestones more predictable, and promotes integration of research and healthcare. As a result, noticeable improvements have been observed in patient satisfaction, cost of care, and outcomes of treatments.”
Solving the big healthcare challenges
In total, close to 700 global startup companies working with digital health in the life sciences and healthcare industry took part in the challenge. Of these, 31 companies have been selected to demonstrate their strengths in the regional rounds held in London, Singapore, and Boston.
Accenture HealthTech Innovation Challenge aims to solve some of the biggest challenges that healthcare face today. Trialbee’s mission to digitalize the clinical trial process through innovative software solutions to integrate clinical research as one option of care ultimately works towards bringing ground-breaking treatments to patients faster.
“Patient engagement in clinical research brings development of new medical interventions closer to healthcare and the end users of new promising drugs, vaccines and medical devices. It is a customer driven approach using digitalized interactions that makes development of medical treatments faster, better, and less costly,” says Max Westling, Business Developer for Trialbee.